RECEPTOR.AI
RECEPTOR.AI speeds early-stage drug discovery by using AI to design and prioritize therapeutic molecules across modalities. The company operates a multimodal TechBio platform that generates and optimizes small molecules, peptides, and induced-proximity therapeutics using generative and predictive models such as ArtiDock and DeepTAG, hierarchical AI-driven workflows, and LLM agents that orchestrate computational and experimental steps. Its infrastructure combines advanced data acquisition, augmentation, and multiparametric optimization of biophysical and ADME properties to enable de novo design and objective comparison of modality strategies. RECEPTOR.AI partners with pharma and biotech and has validated capabilities across 40+ discovery programs to advance high-confidence candidates toward the clinic.
RECEPTOR.AI
RECEPTOR.AI speeds early-stage drug discovery by using AI to design and prioritize therapeutic molecules across modalities. The company operates a multimodal TechBio platform that generates and optimizes small molecules, peptides, and induced-proximity therapeutics using generative and predictive models such as ArtiDock and DeepTAG, hierarchical AI-driven workflows, and LLM agents that orchestrate computational and experimental steps. Its infrastructure combines advanced data acquisition, augmentation, and multiparametric optimization of biophysical and ADME properties to enable de novo design and objective comparison of modality strategies. RECEPTOR.AI partners with pharma and biotech and has validated capabilities across 40+ discovery programs to advance high-confidence candidates toward the clinic.